| Patents for A61K 49 - Preparations for testing in vivo (35,376) |
|---|
| 09/15/2011 | US20110224608 Compound for Local Deletion of Tumors |
| 09/15/2011 | US20110223112 Unsaturated polyester coated magnetic ultra-fine particles for biological applications |
| 09/15/2011 | US20110223111 Calcium carbonate microstructures useful in encapsulation applications and a process for the preparation thereof |
| 09/15/2011 | US20110223110 Stable indium-containing semiconductor nanocrystals |
| 09/15/2011 | US20110223109 Diagnostic substance for use in a method for determining the aggressiveness of a prostate tumor and diagnostic method |
| 09/15/2011 | US20110223108 Glucagon-like peptide-2 and its therapeutic use |
| 09/15/2011 | US20110223107 Antibodies that specifically block the biological activity of a tumor antigen |
| 09/15/2011 | US20110223106 Granin proteins as markers of heart disease |
| 09/15/2011 | US20110223105 New 5-aminolevulinic acid prodrugs for use in photodynamic therapy and photodynamic diagnosis |
| 09/15/2011 | US20110223104 Fluid bed meal containing a marker and methods of making |
| 09/15/2011 | US20110223103 Multimodal Imaging of Atherosclerotic Plaque Targeted to LOX-1 |
| 09/15/2011 | US20110223102 Multimodality agents for tumor imaging and therapy |
| 09/15/2011 | CA2792647A1 Compositions for colon lavage and methods of making and using same |
| 09/15/2011 | CA2786398A1 Radiopaque, non- biodegradable, water - insoluble iodinated benzyl ethers of poly (vinyl alcohol), preparation method thereof, injectable embolizing compositions containing thereof and use thereof |
| 09/14/2011 | EP2364734A1 Multi-component biological transport systems |
| 09/14/2011 | EP1904831B1 Device and method for determining the oxygen concentration of a substance |
| 09/14/2011 | EP1553984B9 Use of a dye for colouring the lens capsule or for colouring epiretinal membranes in the eye |
| 09/14/2011 | CN1845988B Method for immunotherapy of tumors |
| 09/14/2011 | CN1561345B Antibodies to VLA-1 |
| 09/14/2011 | CN102186504A Optical method for the detection of alzheimer's disease |
| 09/14/2011 | CN102181397A Laryngeal squamous cell carcinoma cartilage invasion model |
| 09/14/2011 | CN102180780A Indenone derivative and applications thereof as developing agent and aggregation inhibitor of amyloid protein deposit and neurofibrillary tangle |
| 09/14/2011 | CN102178963A Medical ultrasonic couplant and preparation method of couplant |
| 09/14/2011 | CN102178962A Medical disinfection/sterilization ultrasound couplant and preparation method thereof |
| 09/14/2011 | CN102178961A Gadolinium-gold composite silicone nanomaterial and preparation method and application thereof |
| 09/14/2011 | CN102178568A Animal model constructing method for studying epithelial and stromal hyalinosis of hepatocellular carcinoma |
| 09/14/2011 | CN101845112B Preparation method of high-flexibility nuclear magnetic resonance imaging contrast agents based on high molecular nanometer particles |
| 09/14/2011 | CN101745125B Dual-function chitosan particle and preparation method thereof |
| 09/14/2011 | CN101711880B Preparation and application of superparamagnetic carbon nanotube contrast agent |
| 09/14/2011 | CN101637613B Lipid targeted ultrasound contrast agent and preparation method thereof |
| 09/14/2011 | CN101289460B Organoboronic acid compounds and applications thereof as fluorescent probe |
| 09/13/2011 | US8017736 Alpha-fetoprotein Immu31 antibodies and fusion proteins and methods of use thereof |
| 09/13/2011 | US8017105 Diagnostic imaging contrast agents with extended blood retention |
| 09/13/2011 | US8017104 Large stoke shift dye used for optical imaging |
| 09/13/2011 | US8017103 Methods and compositions to diagnose trichomonas infection |
| 09/13/2011 | CA2494959C Embolization |
| 09/13/2011 | CA2271690C Methods for regulating angiogenesis |
| 09/09/2011 | WO2011109298A2 Therapeutic dll4 binding proteins |
| 09/09/2011 | WO2011108236A1 Radioactive iodine labeled organic compound or salt thereof |
| 09/09/2011 | WO2011107945A1 Solid composition for the oral administration of dyes and diagnostic use thereof |
| 09/09/2011 | WO2011107710A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 09/09/2011 | WO2011107290A1 Magnetic nanoparticles for cancer diagnostic and treatment purposes |
| 09/09/2011 | CA2791648A1 Antibody specific for apolipoprotein and methods of use thereof |
| 09/09/2011 | CA2791631A1 Therapeutic dll4 binding proteins |
| 09/09/2011 | CA2791491A1 Radioactive iodine-labeled organic compound or salt thereof |
| 09/09/2011 | CA2791009A1 Use of riluzole to treat or prevent the adverse effects of antineoplastic agents |
| 09/09/2011 | CA2790143A1 Solid composition for the oral administration of dyes and diagnostic use thereof |
| 09/08/2011 | US20110219463 Methods of screening agents for activity using teleosts |
| 09/08/2011 | US20110218380 Magnetic nanoparticle and group of nanoparticles |
| 09/08/2011 | US20110217243 Pharmaceutical identification |
| 09/08/2011 | US20110217241 Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging |
| 09/08/2011 | US20110217240 Imaging neuroleptic compounds |
| 09/08/2011 | US20110217239 System and method of evaluating a protein of interest on tumor growth inhibition while following the tumor in vivo or in vitro |
| 09/08/2011 | US20110217238 Method of Diagnosing or Prognosing Epithelial Ovarian Cancer |
| 09/08/2011 | US20110217237 Therapeutic dll4 binding proteins |
| 09/08/2011 | US20110217236 Radiation sensitive liposomes |
| 09/08/2011 | US20110217235 Alpha 1-3 n-galactosyltransferase with altered donor specificities |
| 09/08/2011 | US20110217231 Anti-tenascin monoclonal antibody therapy for lymphoma |
| 09/08/2011 | DE102011004987A1 Magnetischer Nanopartikel und Gruppe von Nanopartikeln Magnetic nanoparticles and nanoparticle group |
| 09/07/2011 | EP2363104A1 Hydrogels that undergo volumetric expansion in response to changes in their environment and their methods of manufacture and use |
| 09/07/2011 | CN102176924A Paramagnetic biomolecule complexes and uses thereof in the assessment of organ function |
| 09/07/2011 | CN102174170A Polyurethane material and application thereof as X-ray developing material and magnetic material |
| 09/07/2011 | CN102172411A Nano complex particles with targeted MR (magnetic resonance) development and photothermal therapy performance and preparation method thereof |
| 09/07/2011 | CN102172410A Construction method of targeted nano particle transmission system for cancer diagnosis and treatment |
| 09/07/2011 | CN102172409A Biological assay method and device for detecting toxicity potency of aconite traditional Chinese medicines |
| 09/07/2011 | CN101721717B Method for preparing Fe2O3 nano particle with core-shell structure |
| 09/07/2011 | CN101262817B Multiple contrast agent injection for imaging |
| 09/06/2011 | US8014952 Serum biomarkers in lung cancer |
| 09/06/2011 | US8012476 Molecules with extended half-lives, compositions and uses thereof |
| 09/06/2011 | US8012457 Ultrasound contrast agent dosage formulation |
| 09/06/2011 | US8012456 Biological models capable of exhibiting secondary disease manifestations and useful for developing therapeutic drugs, diagnostic products and therapeutic or diagnostic procedures, methods of using same, and cells, tissues and organs derived therefrom |
| 09/06/2011 | US8012454 Embolization |
| 09/06/2011 | CA2519946C Temporary embolization using inverse thermosensitive polymers |
| 09/06/2011 | CA2498976C Medicinal formulation in particular for treating herniated invertebral discs |
| 09/06/2011 | CA2402774C Microsphere hydrogel biomedical articles |
| 09/01/2011 | WO2011106785A2 Methods of identifying agents effective to treat cognitive decline and diseases associated therewith |
| 09/01/2011 | WO2011106309A2 Materials and methods for mri contrast agents and drug delivery |
| 09/01/2011 | WO2011105736A2 Surface-modified tantalum oxide nanoparticles, preparation method thereof, and contrast medium for x-ray computed tomography and highly dielectric thin film using same |
| 09/01/2011 | WO2011105520A1 Composite body for antigen or drug delivery |
| 09/01/2011 | US20110214191 Method for the identification of genes involved in neurodegenerative processes |
| 09/01/2011 | US20110214189 G protein coupled receptors and uses thereof |
| 09/01/2011 | US20110213293 Ligands to radiation-induced molecules |
| 09/01/2011 | US20110212032 Polymer particles for nir/mr bimodal molecular imaging and method for preparing the same |
| 09/01/2011 | US20110212031 Novel substituted azabenzoxazoles |
| 09/01/2011 | US20110212030 Nucleic Acid Ligand Complexes |
| 09/01/2011 | US20110212029 Detection of cancer |
| 09/01/2011 | US20110212028 Chemically modified cell-penetrating peptides for improved delivery of gene modulating compounds |
| 09/01/2011 | US20110212027 Radiative heating for drug delivery and other applications |
| 09/01/2011 | US20110212026 Butyrylcholinesterase ligands as diagnostic tools and treatment for deseases of the nervous system |
| 09/01/2011 | US20110212025 Tspo-targeting compounds and uses thereof |
| 09/01/2011 | US20110212024 Marker for inflammatory conditions |
| 09/01/2011 | US20110212022 Antitumor antibodies, proteins, and uses thereof |
| 09/01/2011 | DE102009057274B4 Gadobutrolherstellung mittels Trioxobicyclo-octan Gadobutrolherstellung by Trioxobicyclo-octane |
| 09/01/2011 | CA2790577A1 Psma binding ligand-linker conjugates and methods for using |
| 08/31/2011 | EP2361988A1 Molecular marker for cancer stem cell |
| 08/31/2011 | EP2361098A2 Compositions and methods for delivering a substance to a biological target |
| 08/31/2011 | CN102170914A A process for the preparation of aqueous solutions of hyperpolarized molecules |
| 08/31/2011 | CN102170913A Fluorescent emulsion |
| 08/31/2011 | CN102170836A Method and device for marking a medium, and marker usable in such a method |
| 08/31/2011 | CN102167813A Fluorescent tracing nanometer magnetic resonance imaging contrast agent |